ACCN - Adriatic Club of Clinical Nutrition and Metabolism’s Post

ISPOR Bulgarian Chapter "SEE YOU IN BARCELONA" part I Do HTA Process in Central and Eastern Europe Countries Improve the Availability and Accessibility of Advanced Therapies? A multidisciplinary team from ISPOR Bulgarian Chapter and the ISPOR CEE Consortium reviewed the progress od ATMPs market access over a 3-year period in Bulgaria, Romania and Poland. The results will be presented at the ISPOR Europe 2024, 📍 Barcelona, Spain 🔈 Code HTA342 One of the main challenges outlined in the analysis are: 💡 high treatment costs 💡 uncertainty in clinical effectiveness 💡 inadequate HTA methodological approaches Meet the authors - Boryana Ivanova, Adina Turcu-Stiolica, Manoela Manova, Alexandra Savova J  Gierczyński, MS Naidin, Martin Czech, Guenka Petrova and Marija Kamusheva at the ISPOR Europe 2024 to discuss the possible solutions or wait for our feedback after the congress!

Exciting news ! RPSA ( Rwanda Pharmaceutical Student Association ) was prepared Second Scientific Conference focusing on Pandemic preparedness under the theme "Fostering Public -Private Partnerships to establish Resilient Healthcare infrastructure in Rwanda ". what you can expects to benefit from attending that conference . ✅ Engage with healthcare professionals, policymakers, industry leaders , and fellow participants passionate about strengthening Rwanda's healthcare system. ✅ Gain insights about best practices for building resilient healthcare systems through public-private partnerships and participate in interactive discussions addressing Rwanda's unique challenges and opportunities in pandemic preparedness. ✅ collaborate with others to create impactful solutions and position yourself as an advocate for improved healthcare resilience within your community or organization. ✅ And more RPSA scientific conference is the annual event which gathers medical students ,pharmacists , and stakeholders in healthcare sector to discuss different challenges regarding to public health . I can't wait to see you at lemigo Hotel , Kigali city. Book your spots via https://lnkd.in/d-qjaCCv Deadline : 3rd February,2025. IPSF - International Pharmaceutical Students' FederationRwanda Biomedical CentreUniversity of Rwanda Public Health Students' AssociationRwanda Pharmaceutical Students Association (RPSA/AEPHAR)Rwanda FDAUnited Nations Development Programme (UNDP)Yvan ButeraProf. Claude Mambo MuvunyiDarius Uzabakiriho #RPSA SciCon25 #Pandemic Preparedness.

DCOIWA gears up for 2nd Annual Congress #2ndAnnualCongress #AnnualGeneralMeeting #AwardsandRecognition #DCOIWA #DrugAct #DrugsControlOfficersWelfareAssociation #GKoteshwarRao #IndustryInteraction #MembershipDrive #Mumbai #Pharmaceuticalindustry #SeminarsandWorkshops

GPP, a rare, chronic, systemic, autoimmune disease is potentially life threatening if left untreated. It can have an enormous impact on the lives of those who live with a constant fear of flares. We recognize this burden and are committed to addressing unmet medical needs like GPP, driven by our legacy of innovation. By collaborating with medical experts, we gain insights vital to understanding patients' real challenges. Through the GPP Summit, we aim to build a forum that facilitates discussions on treatment guidelines, fostering best practices exchange with the experts in the field. We believe that together, we can improve patient outcomes and transform lives affected by GPP.

Among the finalists of 10th International Medis Awards were three Slovenian researchers:   🔬 Dr. Jure Urbancic, who researched chronic rhinosinusitis, shedding light on its molecular and genetic events. His work aims to develop targeted biologics and improve treatment for this inflammatory disease.   💊 Dr. Lea Knez, who analyzed the effectiveness of immunotherapy in treating lung cancer patients. Her findings indicate promising results comparable to clinical trials, paving the way for better treatment outcomes in routine clinical practice.   👩⚕️ Dr. Luka Roškar, who explored molecular characteristics of endometrial cancer, aiming for more accurate early diagnosis and tailored therapeutic approaches.   📰 To read extensive article about their research, visit the newspaper Delo website (in Slovenian) 👉 https://lnkd.in/dp3ha5fg   #MedisAwards #MedicalResearch #SlovenianResearchers

DCOIWA gears up for 2nd Annual Congress #2ndAnnualCongress #AnnualGeneralMeeting #AwardsandRecognition #DCOIWA #DrugAct #DrugsControlOfficersWelfareAssociation #GKoteshwarRao #IndustryInteraction #MembershipDrive #Mumbai #Pharmaceuticalindustry #SeminarsandWorkshops

We were honored to chair the insightful session where Niklas Blomberg , Executive Director of the Innovative Health Initiative (Innovative Health Initiative (IHI) ), shared his perspectives on "Navigating Tomorrow: Insights on Horizon Scanning and Public-Private Collaborative Support Strategies." During his 10-minute talk, Niklas highlighted the critical role of IHI as an EU public-private partnership in funding health research and innovation to address the pressing public health needs of today and tomorrow. This session was part of the European Medicines Agency's 10-year celebration of the EU Network Training Centre (EU NTC), marking a decade of collaborative efforts in advancing medical innovation and regulatory science. Niklas provided an update on the progress from the recent IHI Regulatory Summit, emphasizing the importance of collaborative efforts in driving health innovation forward. We are proud to collaborate with IHI on several key projects where the European Liver Patients' Association (ELPA) plays a significant role: GRIPonMASH: Aiming to transform the detection and management of Metabolic dysfunction-Associated Steatohepatitis (#MASH) to reduce disease burden and improve patient outcomes. LIVERAIM : Developing a biomarker-based platform for the early diagnosis of chronic liver disease, enabling personalized therapy and reducing morbidity and mortality. These collaborations exemplify our commitment to advancing health research and innovation through strategic partnerships. #HealthInnovation #PublicPrivatePartnership #Research #Healthcare #IHI #ELPA #GRIPonNASH #LIVERAIM #EMA #EUNTC EU Health and Food Safety European Health and Digital Executive Agency (HaDEA) WHO Regional Office for Europe Belgian Presidency of the Council of the European Union 2024 European Commission EASL the home of Hepatology Aleksander Krag Marko Korenjak Manuel Romero Gomez Veronika Všetíčková MSc Milan Mishkovikj, M.A. European Parliament Anastassiya Semeiskaya European Medicines Agency Emer Cooke

DCOIWA gears up for 2nd Annual Congress #2ndAnnualCongress #AnnualGeneralMeeting #AwardsandRecognition #DCOIWA #DrugAct #DrugsControlOfficersWelfareAssociation #GKoteshwarRao #IndustryInteraction #MembershipDrive #Mumbai #Pharmaceuticalindustry #SeminarsandWorkshops

It is a dream come true; I know it sounds like a shallow soundbite, but it is anything but… 6 years ago I had such a dream. The dream of patients being in control of their data, being able to measure how they are doing in a way that is understood by healthcare providers and being able to be to part of any decision that affects their lives. Not out of pity or compassion; but because they have the data and the evidence to prove their point. 6 years ago the #EHDS was not even at the horizon; however there is a tremendous opportunity for synergies now. The Pan-European Observatory can serve as a forum to achieve consensus on what can be measured digitally in routine care in order to improve care and fuel the EHDS with standardized outcome data. At the same time, the data access framework developed through the H2O project offers a blueprint on how to manage data by relying on the Patient Agreement. H2O through the leadership of the Pan-European Health Outcomes Observatory can pave the way on how to build the EHDS on the foundation of 'Data Trusts' and multi-stakeholder consensus on what to measure and how.

It has been fantastic to round off the year with a fruitful workshop on evolving and enhancing multiple sclerosis (MS) care. Roche Gulf Cluster, Roche Türkiye, and Roche Serbia were honoured to organise “Bridging Borders”, an experience-sharing event that brought together leading experts from Bahrain, Kuwait, Oman, Qatar, Serbia, and Türkiye to present real-world data on MS registries. Our goal? To explore current care models in each region, the real-world data of those treatment centres based in each country and identify how to further improve MS management moving forwards. “Bridging Borders” provided an excellent opportunity for healthcare professionals to present their registries’ data and insights. It was extremely interesting to learn more about how global clinical research is translated in each region, as well as how it compares to actual real-world practices in their respective territory. Events of this kind are important to Roche Gulf Cluster, as they highlight local and regional real-world data, and thus offer healthcare regulators and providers the most accurate information on what is needed next in MS care. I look forward to the next one.